ABSTRACT
La diferenciación entre abscesos y metástasis cerebrales en pacientes con algún grado de inmunosupresión y con neoplasias hematológicas resulta en ocasiones difícil. Los estudios funcionales como la tomografía de emisión de fotón único (SPECT) y la tomografía por emisión de positrones (PET) son herramientas diagnósticas eficaces para este propósito. Presentamos el caso de una paciente con diagnóstico de leucemia mieloide crónica en crisis blástica a quien se le informó múltiples abscesos cerebrales; diagnóstico basado en que no existió captación de 99mTc - MIBI en SPECT cerebral y en la buena respuesta al tratamiento antimicrobiano en ocasión en que los estudios de tomografía computarizada (TC) cerebral y resonancia magnética (RM) cerebral no fueron concluyentes. Teniendo en cuenta los resultados de la SPECT se decidió postergar el esquema de quimioterapia, ya que esta podría desencadenar complicaciones probablemente fatales en la paciente.
The differentiation between brain abscess and brain metastasis in patients with some grade of immune suppression and hematological neoplasm is difficult in some situations. Functional studies like Single-Photon Emission Tomography (SPECT) and Positron Emission Tomography (PET) are useful for this purpose. We present the case of a patient with diagnosis of chronic myelogenous leukemia in blast crisis that a diagnosis of brain abscess was made. The diagnosis had a base in 99mTc - MIBI brain SPECT did not show MIBI uptake and the good treatment response to antibiotics when brain CT scan and MRI were not conclusive. Attending to the SPECT result, chemotherapy was postponed because of probably fatal complications in this patient with brain abscess.
ABSTRACT
Objective To evaluate the utility of a new multimodal image-guided intervention technique to detect epileptogenic areas with a gamma probe as compared with intraoperative electrocorticography. Materials and Methods Two symptomatic patients with refractory epilepsy underwent magnetic resonance imaging, videoelectroencephalography, brain SPECT scan, neuropsychological evaluation and were submitted to gamma probe-assisted surgery. Results In patient 1, maximum radioactive count was initially observed on the temporal gyrus at about 3.5 cm posteriorly to the tip of the left temporal lobe. After corticotomy, the gamma probe indicated maximum count at the head of the hippocampus, in agreement with the findings of intraoperative electrocorticography. In patient 2, maximum count was observed in the occipital region at the transition between the temporal and parietal lobes (right hemisphere). During the surgery, the area of epileptogenic activity mapped at electrocorticography was also delimited, demarcated, and compared with the gamma probe findings. After lesionectomy, new radioactive counts were performed both in the patients and on the surgical specimens (ex-vivo). Conclusion The comparison between intraoperative electrocorticography and gamma probe-assisted surgery showed similarity of both methods. The advantages of gamma probe include: noninvasiveness, low cost and capacity to demonstrate decrease in the radioactive activity at the site of excision after lesionectomy. .
Objetivo Avaliar a utilidade de um novo método de intervenção multimodal guiado por imagem, permitindo a detecção de áreas epileptogênicas mediante utilização de gamaprobe em comparação à eletrocorticografia intraoperatória. Materiais e Métodos Dois pacientes sintomáticos com epilepsia refratária realizaram ressonância magnética, videoeletroencefalograma, SPECT cerebral, avaliação neuropsicológica e foram submetidos a neurocirurgia usando gamaprobe. Resultados No paciente 1 as contagens radioativas inicialmente estavam no máximo no giro temporal, cerca de 3,5 cm posterior à ponta do lobo temporal esquerdo. Após corticotomia, o gamaprobe apontou o ponto máximo na cabeça do hipocampo, de acordo com os achados de eletrocorticografia intraoperatória. No paciente 2 as contagens foram máximas na região occipital em sua transição com os lobos temporal e parietal (hemisfério direito). Na cirurgia, a área mapeada da atividade epileptogênica na eletrocorticografia foi também delimitada, demarcada e comparada aos dados do gamaprobe. Após a lesionectomia, procedeu-se uma nova radiocontagem no paciente e na peça cirúrgica (ex-vivo). Conclusão A comparação entre os métodos mostrou acurácia praticamente similar. As vantagens do gamaprobe foram a de não ser invasivo, ser de baixo custo e também ser relevante para mostrar a redução da atividade radioativa no local da exérese. .
ABSTRACT
OBJECTIVE: To make individual assessments using automated quantification methodology in order to screen for perfusion abnormalities in cerebral SPECT examinations among a sample of subjects with OCD. METHODS: Statistical parametric mapping (SPM) was used to compare 26 brain SPECT images from patients with OCD individually with an image bank of 32 normal subjects, using the statistical threshold of p < 0.05 (corrected for multiple comparisons at the level of individual voxels or clusters). The maps were analyzed, and regions presenting voxels that remained above this threshold were sought. RESULTS: Six patients from a sample of 26 OCD images showed abnormalities at cluster or voxel level, considering the criteria described above, which represented 23.07 percent. However, seven images from the normal group of 32 were also indicated as cases of perfusional abnormality, representing 21.8 percent of the sample. CONCLUSION: The automated quantification method was not considered to be a useful tool for clinical practice, for analyses complementary to visual inspection.
OBJETIVO: Avaliar uma amostra de pacientes com transtorno obsessivo-compulsivo (TOC), individualmente, empregando uma metodologia de quantificação automatizada para rastrear anormalidades de perfusão em exames de SPECT cerebral. MÉTODOS: Foi utilizado o Statistical Parametric Mapping (SPM) para comparar 26 imagens de SPECT cerebral de pacientes com TOC, individualmente, com um banco de 32 imagens de voluntários normais, usando o limiar estatístico de p < 0,05 (corrigido para comparações múltiplas ao nível do voxel individual ou clusters). Os mapas foram analisados procurando por regiões que apresentassem voxels acima desse limiar. RESULTADOS: Seis pacientes da amostra de 26 imagens com TOC mostraram anormalidades ao nível do cluster ou voxel, considerando os critérios descritos acima, os quais representaram 23,07 por cento. Contudo, sete imagens do grupo de 32 voluntários normais também foram apontadas com anormalidades de perfusão, que representou 21,8 por cento da amostra. CONCLUSÃO: O método de quantificação automatizada não foi considerado como uma ferramenta útil na prática clínica, como forma de análise complementar à inspeção visual.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Obsessive-Compulsive Disorder/diagnosis , Obsessive-Compulsive Disorder/physiopathology , Brazil , Magnetic Resonance Imaging , Brain Mapping/methods , Tomography, Emission-Computed, Single-Photon/methodsABSTRACT
Objetivo: Estudiar el valor del SPECT cerebral en el diagnóstico y control evolutivo del compromiso del SNC en las enfermedades colágenovasculares (ECV) con sintomatología neuropsiquiátrica (SNP). Materiales y métodos: Se analizaron retrospectivamente 31 pacientes consecutivos portadores de ECV con SNP evaluados mediante SPECT cerebral con 99mTc-ECD y mapas estadísticos de superficie cortical. Veintiuno de ellos presentaban LES y 6 una enfermedad de Behçet. A 18 pacientes se efectuó además TC, a 8 RM y a 10 estudio neuropsicológico (ENP). Seis pacientes se realizaron SPECT de control. Resultados: Veintiocho pacientes presentaron SPECT patológico. La TC fue anormal en sólo 3/18 (sensibilidad 90,3 por ciento vs. 16,7 por ciento; p<0,001). La RM mostró alteraciones en 5/8 pacientes y el ENP en 7/10. Aunque todos estos pacientes presentaron SPECT patológico, los valores de sensibilidad no difirieron significativamente. Los pacientes con mayor SNP presentaron trastornos de perfusión más extensos (p<0,035). Los pacientes estudiados evolutivamente mostraron mejoría de los defectos con la respuesta al tratamiento y agravamiento con la reaparición de síntomas. Conclusiones: El SPECT cerebral presenta elevada sensibilidad en la detección del compromiso neuropsiquiátrico en las ECV. Su utilidad podría extenderse al control evolutivo y la evaluación de la respuesta terapéutica.
Objetive: To study the value of brain SPECT in the diagnosis and follow up of SNC involvement in systemic connective tissue diseases (SCTD) with neuropsychiatric symptoms (NPS). Materials and methods: We retrospectively analyzed 31 consecutive patients with SCTD presenting with NPS who underwent 99mTc-ECD SPECT and statistical surface maps. 21 patients had systemic lupus erythematosus and 3 had Behçet disease. Results were compared to those of CT (18/31), MRI (8/31) and neuropsychological examination (NPE). 6 patients had follow-up SPECT scans. Results: Twenty-eight patients had abnormal SPECT studies. CT was abnormal in 3/18 patients (sensitivity 90.3 percent vs. 16.7 percent; p<0.001). MRI showed alterations in 5/8 patients and NPE in 7/10. Although all these patients presented abnormal SPECT scans, sensitivity values were not statistically different. Patients with major NPS presented more extensive perfusion defects (p<0.035). Patients with follow-up SPECT scans showed perfusion improvement with response to treatment and progression of the alterations when symptoms relapsed. Conclusion: Brain SPECT presents high sensitivity for the detection of neurological involvement in SCTD. SPECT usefulness may extend to follow-up and evaluation of response to treatment.
Subject(s)
Humans , Male , Adolescent , Adult , Female , Middle Aged , Cerebrum , Connective Tissue Diseases , Connective Tissue Diseases/complications , Tomography, Emission-Computed, Single-Photon/methods , Cerebrovascular Circulation , Organotechnetium Compounds , Nervous System Diseases/etiology , Retrospective Studies , Follow-Up Studies , Regional Blood Flow , Lupus Erythematosus, Systemic , Lupus Erythematosus, Systemic/complications , Sensitivity and Specificity , Behcet Syndrome , Behcet Syndrome/complications , Mental Disorders/etiologyABSTRACT
El abuso de sustancias psicotóxicas representa un gran problema de Salud Pública en los diferentes distritos estatales. Este trabajo pretende determinar cuáles son los efectos nocivos de estas sustancias sobre el parénquima cerebral de los pacientes en los que se ha demostrado un consumo activo de drogas prohibidas. Para ello se empleó la técnica de SPECT cerebral con ECD - 99mTc aplicada a aquellos pacientes adictos, a los cuales previamente se les realizó una encuesta para conocer el tipo de droga, el tiempo y la duración de su adicción. Como resultado se detectó que el mayor número de defectos de perfusión corticales, es decir, déficits funcionales, se localizaron en la corteza órbito-frontal y en los lóbulos temporales, lo cual explicaría los importantes trastornos de conducta y personalidad que manifiestan estos pacientes. Se demostró con este método que el SPECT cerebral es un excelente método para detectar las zonas afectadas por estas drogas psicoadictivas, su extensión y la evolución y posible respuesta al tratamiento.
Psychoactive drug abuse is a major public health problem in many districts. This study seeks to determine the harmful effects of such drugs on the brain parenchyma of patients known to abuse illegal drugs. Brain scans were obtained using 99 M Tc- ECD SPECT from drug addicts that had been previously surveyed to ascertain the type of drug, the timing and duration of their addiction SPECT findings showed a larger number of cortical perfusion defects, that is to say functional defects located in the orbital-frontal cortex and in the temporal lobes that may explain the significant behavior and personality disorders these patients display. Cerebral SPECT showed to be an excellent method to detect areas affected by psychoactive drugs, their extent, likely evolution and response to treatment.
ABSTRACT
OBJECTIVE: To compare the accuracy of SPM and visual analysis of brain SPECT in patients with mesial temporal lobe epilepsy (MTLE). METHOD: Interictal and ictal SPECTs of 22 patients with MTLE were performed. Visual analysis were performed in interictal (VISUAL(inter)) and ictal (VISUAL(ictal/inter)) studies. SPM analysis consisted of comparing interictal (SPM(inter)) and ictal SPECTs (SPM(ictal)) of each patient to control group and by comparing perfusion of temporal lobes in ictal and interictal studies among themselves (SPM(ictal/inter)). RESULTS: For detection of the epileptogenic focus, the sensitivities were as follows: VISUAL(inter)=68 percent; VISUAL(ictal/inter)=100 percent; SPM(inter)=45 percent; SPM(ictal)=64 percent and SPM(ictal/inter)=77 percent. SPM was able to detect more areas of hyperperfusion and hypoperfusion. CONCLUSION: SPM did not improve the sensitivity to detect epileptogenic focus. However, SPM detected different regions of hypoperfusion and hyperperfusion and is therefore a helpful tool for better understand pathophysiology of seizures in MTLE.
OBJETIVO: Comparar a acurácia do SPM com a análise visual na detecção do foco epileptogênico e alterações perfusionais à distância no SPECT cerebral. MÉTODO: Foram realizados os SPECTs ictal e interictal de 22 pacientes com epilepsia de lobo temporal mesial (ELTM). A análise visual foi realizada nos estudos interictal (VISUAL(inter)) e ictal (VISUAL(ictal/inter)). Na análise com SPM foi comparado o estudo interictal (SPM(inter)) e ictal (SPM(ictal)) de cada paciente com o grupo controle e comparou-se a perfusão dos lobos temporais entre os estudos ictal e interictal (SPM(ictal/inter)). RESULTADOS: Para a detecção do foco epileptogênico, as sensibilidades foram as seguintes: VISUAL(inter)=68 por cento; VISUAL(ictal/inter)=100 por cento; SPM(inter)=45 por cento; SPM(ictal)=64 por cento and SPM(ictal/inter)=77 por cento. O SPM foi capaz de detectar mais áreas de hiperperfusão e hipoperfusão. CONCLUSÃO: O SPM não aumentou a sensibilidade na detecção do foco epileptogênico. Entretanto, o SPM detectou diferentes regiões de hipoperfusão e hiperperfusão e portanto, ele pode ser uma ferramenta de ajuda para se melhor entender a patofisiologia das crises na ELTM.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , Brain Mapping/methods , Epilepsy, Temporal Lobe , Tomography, Emission-Computed, Single-Photon , Brain/blood supply , Case-Control Studies , Chronic Disease , Electroencephalography , Epilepsy, Temporal Lobe/physiopathology , Image Processing, Computer-Assisted , Magnetic Resonance ImagingABSTRACT
Technetium-99m-d,1-hexamethylpropyleamine oxime (99mTc-HMPAO) is an important radiopharmaceutical used for both brain SPECT imaging and "in vitro" labelling of white blood cells. An increasing utilization of this radiopharmaceutical for studies of several neurologic and psychiatric diseases in humans, lead us to the preparation of the kits of HMPAO to be labeled with technetium-99m. This paper presents animal experimental studies with d,l-HMPAO99mTc prepared from liofilized kits developed in our laboratories and also comparison to those commercially available. The brain scans have been done initially in rabbits, however better results were obtained with dogs. Six mongrel dogs clinically qualited as normals, were used in order to get scintigraphic brain pictures and washout curves of region of interest (ROIs). The value of experimental studies in animals and the considerable reduction in price of the so obtained radiopharmaceutical, have shown the viability of such procedure in the clinical practice as well in the veterinary clinic of small animals. By the other side, the perfusion of d,l-HMPAO99mTc showed that such a product concentrates at the same time in the cerebral area and nasal fossa, showing evidence of similar structures as the hemato encephalic barrier, also in the nasal area.
O d,1 - Hexametilpropileno oxima marcado com o tecnécio-99m(99mTc-HMPAO) é um importante radiofármaco usado tanto para imagens tomográficas cerebrais quanto na marcação in vitro" de leucócitos. A crescente utilização deste radiofármaco no estudo de doenças neurológicas no homem levou-nos à obtenção de "kits" de HMPAO para ser marcado pelo tecnécio-99m. Neste trabalho apresentamos o estudo experimental efetuado com "kits" liofilizados de d,1 HMPAO99mTc desenvolvidos em nossos laboratórios, comparando inclusive com aqueles encontrados no comércio. As imagens cerebrais inicialmente foram feitas em coelhos, entretanto os melhores resultados foram obtidos em cães. Assim, selecionaram-se seis cães sem raça definida, considerados clinicamente normais para obtenção das imagens cintilográficas do cérebro e o washout das regiões de interesse (ROls). Os estudos experimentais em animais e a considerável redução do custo do radiofármaco mostrou-nos a possibilidade da utilização destes exames na clínica veterinária, especialmente de pequenos animais. Por outro lado, a perfusão do d,l HMPAO99mTc mostra que a concentração do radiofármaco se faz ao mesmo tempo na região do cérebro e nas fossas nasais, demonstrando a existência de estruturas iguais às da barreira hemo-encefálica nesta última região.